Back
Aldeyra Therapeutics Vs. AbbVie Industry Stock Comparison
Sell
30
ALDX
Aldeyra Therapeutics
Last Price:
4.21
Seasonality Move:
5.49%
Sell
31
ABBV
AbbVie
Last Price:
164.94
Seasonality Move:
4.77%
Sell
30
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $4.21. The Score for ALDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $164.99. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight buying pressure.
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 28.96 | Sell |
| Chaikin Money Flow: | -517 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.87 - 5.69) | Sell |
| Bollinger Bands (100): | (3.98 - 5.8) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.7 | Sell |
| Relative Strength Index (14 RSI): | 22.5 | Sell |
| Chaikin Money Flow: | -9931148 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (178.46 - 201.02) | Sell |
| Bollinger Bands (100): | (176.57 - 198.61) | Sell |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.92 | Sell |
| 20-day SMA: | 5.22 | Sell |
| 50-day SMA: | 5.46 | Sell |
| 200-day SMA: | 4.29 | Sell |
| 8-day EMA: | 4.74 | Sell |
| 20-day EMA: | 5.08 | Sell |
| 50-day EMA: | 5.2 | Sell |
| 200-day EMA: | 4.75 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181.46 | Sell |
| 20-day SMA: | 189.13 | Sell |
| 50-day SMA: | 192.14 | Sell |
| 200-day SMA: | 178.83 | Sell |
| 8-day EMA: | 177.72 | Sell |
| 20-day EMA: | 186.06 | Sell |
| 50-day EMA: | 189.37 | Sell |
| 200-day EMA: | 179.02 | Sell |
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.14 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.19 per share.
Aldeyra Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||